Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 17027
Country/Region: South Africa
Year: 2016
Main Partner: University of the Witwatersrand
Main Partner Program: Wits Reproductive Health and HIV Institute
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $1,439,732 Additional Pipeline Funding: $375,776

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $267,887
Care: TB/HIV (HVTB) $289,180
Care: Pediatric Care and Support (PDCS) $43,922
Testing: HIV Testing and Counseling (HVCT) $150,000
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $12,067
Treatment: Adult Treatment (HTXS) $632,754
Treatment: Pediatric Treatment (PDTX) $43,922
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Age/sex: 15-19 Female 2017 98
HTS_TST Age/sex: 15-19 Male 2017 225
HTS_TST Age/sex: 20-24 Female 2017 1,809
HTS_TST Age/sex: 20-24 Male 2017 2,327
HTS_TST Age/sex: 25-49 Female 2017 4,475
HTS_TST Age/sex: 25-49 Male 2017 5,608
HTS_TST Age/sex: 50+ Male 2017 49
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 7,830
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 11,423
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 19,253
HTS_TST Service Delivery Point (Community): Mobile testing 2017 13,669
HTS_TST Service Delivery Point (Facility): Other PITC 2017 5,584
HTS_TST Sum of Age/Sex disaggregates 2017 14,591
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 19,253
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 19,253
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 12
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 23
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 183
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 388
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 448
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 560
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 6
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 942
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 1,249
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 14,860
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2017 14,860
KP_PREV Total estimated number of key population in the catchment area 2017 37,334
KP_PREV_den By key population type: Female sex workers (FSW) (Denominator: Total estimated number of key population in the catchment area) 2017 28,374
KP_PREV_den By key population type: Men who have sex with men who are sex workers (Denominator: Total estimated number of key population in the catchment area 2017 8,960
PP_PREV Aggregated Age/sex: 15+ Female 2017 2,202
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2017 2,202
PP_PREV Total number of people in the target population 2017 936,690
PrEP_NEW Female 20-24 2017 835
PrEP_NEW Number of individuals who have received antiretroviral preexposure 2017 835
TX_CURR Age/Sex: 15-19 Female 2017 36
TX_CURR Age/Sex: 20-24 Female 2017 130
TX_CURR Age/Sex: 20-24 Male 2017 86
TX_CURR Age/Sex: 25-49 Female 2017 460
TX_CURR Age/Sex: 25-49 Male 2017 308
TX_CURR Age/Sex: 50+ Female 2017 28
TX_CURR Age/Sex: 50+ Male 2017 32
TX_CURR Aggregated Age/Sex: 15+ Female 2017 1,324
TX_CURR Aggregated Age/Sex: 15+ Male 2017 836
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 2,160
TX_CURR Sum of age/sex disaggregates 2017 36
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 2,160
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 2,160
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 1,011
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 477
TX_NEW By Age/Sex: 15-19 Female 2017 14
TX_NEW By Age/Sex: 15-19 Male 2017 2
TX_NEW By Age/Sex: 20-24 Female 2017 40
TX_NEW By Age/Sex: 20-24 Male 2017 24
TX_NEW By Age/Sex: 25-49 Female 2017 472
TX_NEW By Age/Sex: 25-49 Male 2017 136
TX_NEW By Age/Sex: 50+ Female 2017 24
TX_NEW By Age/Sex: 50+ Male 2017 32
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 1,488
TX_NEW Sum of Age/Sex disaggregates 2017 744
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 1,488
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 1,944
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 1,752
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 1,048
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 704
TX_PVLS Numerator: Indication: Routine 2017 1,752
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 1,168
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 776
TX_PVLS_den Denominator: Indication: Routine 2017 1,944
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 20
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 12
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 72
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 52
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 508
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 352
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,208
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 824
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 2,032
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 2,160
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 20
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 12
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 76
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 56
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 540
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 376
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,284
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 876
Cross Cutting Budget Categories and Known Amounts Total: $1,473,760
Condoms: Policy, Tools, and Services $404,699
Human Resources for Health $330,954
Key Populations: Sex Workers $65,559
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Training of health workers and community outreach workers
Collection and use of strategic information on SWs and clients
Monitoring and evaluation of SW programs
Key Populations: MSM and TG $585,048
Training of health workers and community outreach workers
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Collection and use of strategic information
Monitoring and evaluation of MSM/TG programs
Motor Vehicles: Purchased $87,500